NCT06529107 Conversion of Evidence and Applied Research on Intermittent Catheterization After Radical Hysterectomy
| NCT ID | NCT06529107 |
| Status | Recruiting |
| Phase | — |
| Sponsor | West China Second University Hospital |
| Condition | Intermittent Catheterization |
| Study Type | INTERVENTIONAL |
| Enrollment | 70 participants |
| Start Date | 2024-01-01 |
| Primary Completion | 2024-12-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 70 participants in total. It began in 2024-01-01 with a primary completion date of 2024-12-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In this study, the investigators summarize the existing best evidence of intermittent catheterization in patients after radical cervical cancer surgery from the perspective of clinical translation of evidence through systematic search, evaluation and evidence integration, construct a nursing protocol of intermittent catheterization for patients after radical cervical cancer surgery based on the best evidence combined with the clinical context, and explore the clinical application effect of the above nursing protocol. It will provide a reference basis for the development of the standardization and management of intermittent catheterization for postoperative patients with cervical cancer in China, as well as the development of guidelines for intermittent catheterization after radical cervical cancer surgery.
Eligibility Criteria
Inclusion Criteria: * Age ≧ 18 years old * Radical cervical cancer surgery and intermittent catheterization were performed at the Institute's hospital * Patients or their family members can operate a smartphone * No cognitive or psychiatric disorders, and can communicate effectively Exclusion Criteria: * People with serious heart, brain, lung and other important organ diseases * People with water, electrolyte, acid-base balance disorders at the beginning of intermittent catheterization * People with previous serious renal diseases, bladder and urethra surgery * People with urinary tract infections * People who did not complete all interventions or data collection * People who voluntarily withdrew from the study or died during the study period; * Refuse to participate in this study
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06529107 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Intermittent Catheterization. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06529107 currently recruiting?
Yes, NCT06529107 is actively recruiting participants. Contact the research team at xinglu_0707@163.com for enrollment information.
Where is the NCT06529107 trial being conducted?
This trial is being conducted at Chengdu, China.
Who is sponsoring the NCT06529107 clinical trial?
NCT06529107 is sponsored by West China Second University Hospital. The trial plans to enroll 70 participants.